Ravgen, Inc. v. Myriad Genetics, Inc. et al
Plaintiff: Ravgen, Inc.
Defendant: Myriad Women's Health, Inc. and Myriad Genetics, Inc.
Case Number: 1:2020cv01730
Filed: December 21, 2020
Court: US District Court for the District of Delaware
Presiding Judge: Richard G Andrews
Referring Judge: Jennifer L Hall
Nature of Suit: Patent
Cause of Action: 35 U.S.C. § 271
Jury Demanded By: Plaintiff
Docket Report

This docket was last retrieved on March 15, 2021. A more recent docket listing may be available from PACER.

Date Filed Document Text
March 15, 2021 Filing 12 STIPULATION TO EXTEND TIME for the submission of the proposed Scheduling Order and joint letter to 3/29/2021 - filed by Ravgen, Inc.. (Farnan, Brian)
March 15, 2021 Opinion or Order SO ORDERED, Stipulation to Extend Time for the submission of the Proposed Scheduling Order and Joint Letter to 3/29/2021. (C.A. No. 20-cv-1644, D.I. 13; C.A. No. 20-cv-1646, D.I. 22; C.A. No 20-cv-1730, D.I. 12). ORDERED by Judge Jennifer L. Hall on 3/15/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH(ceg)
February 12, 2021 Opinion or Order Filing 11 ORAL ORDER: IT IS HEREBY ORDERED that, within thirty days, the parties shall jointly prepare and file the following: (i) a proposed Scheduling Order consistent with Judge Hall's "Rule 16 Scheduling Order - Patent" up through and including paragraph number 17 (i.e., up to and including case dispositive motions) and consistent with paragraphs 13-16 of Judge Andrew's "Rule 16 Scheduling Order - Patent"; and (ii) a letter, not to exceed three pages, setting forth (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order; and (c) a list of any other issues the parties want to address at the Rule 16 Scheduling Conference. Thereafter, the Court may schedule a Rule 16 Scheduling Conference to be held with Judge Hall. The Scheduling Orders can be found on Judge Hall's and Judge Andrew's portions of the District Court's website. ORDERED by Judge Jennifer L. Hall on 2/12/2021. (ceg)
February 11, 2021 Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Myriad Genetics, Inc. for Myriad Women's Health, Inc.; Other Affiliate BlackRock Institutional Trust Company, N.A. for Myriad Genetics, Inc. filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. (Blumenfeld, Jack)
February 11, 2021 Filing 9 ANSWER to #1 Complaint, by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Blumenfeld, Jack)
January 13, 2021 Opinion or Order ORAL ORDER: The case is now referred to Magistrate Judge Jennifer L. Hall for all purposes through the case dispositive motion deadline. Ordered by Judge Richard G. Andrews on 1/13/2021. Associated Cases: 1:20-cv-01644-RGA, 1:20-cv-01646-RGA, 1:20-cv-01730-RGA, 1:20-cv-01734-RGA(nms)
January 7, 2021 Pro Hac Vice Attorneys John M. Desmarais, Kerri-Ann Limbeek, Jamie L. Kringstein, Brian D. Matty, Michael Ling, Deborah J. Mariottini for Ravgen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
January 5, 2021 Filing 8 MOTION for Pro Hac Vice Appearance of Attorney John M. Desmarais, Kerri-Ann Limbeek, Jamie L. Kringstein, Brian D. Matty, Michael Ling, and Deborah J. Mariottini - filed by Ravgen, Inc.. (Farnan, Brian)
January 5, 2021 Opinion or Order SO ORDERED, re (7 in 20-cv-1734-RGA; 8 in 20-cv-1730-RGA) MOTION for Pro Hac Vice Appearance of Attorney John M. Desmarais, Kerri-Ann Limbeek, Jamie L. Kringstein, Brian D. Matty, Michael Ling, and Deborah J. Mariottini, filed by Ravgen, Inc.. Signed by Judge Richard G. Andrews on 1/5/2021. Associated Cases: 1:20-cv-01730-RGA, 1:20-cv-01734-RGA(nms)
December 29, 2020 Filing 7 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Ravgen, Inc.. (Farnan, Michael)
December 29, 2020 Filing 6 STIPULATION TO EXTEND TIME for defendants to respond to the Complaint to February 11, 2021 - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. (Blumenfeld, Jack)
December 29, 2020 Opinion or Order SO ORDERED, re #6 STIPULATION and Order (*Reset Answer Deadlines: Myriad Genetics, Inc. answer due 2/11/2021; Myriad Women's Health, Inc. answer due 2/11/2021). Signed by Judge Richard G. Andrews on 12/29/2020. (nms)
December 23, 2020 Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:20-cv-01730-RGA, 1:20-cv-01734-RGA (rjb)
December 22, 2020 Filing 5 SUMMONS Returned Executed by Ravgen, Inc.. Myriad Genetics, Inc. served on 12/22/2020, answer due 1/12/2021; Myriad Women's Health, Inc. served on 12/22/2020, answer due 1/12/2021. (Farnan, Michael)
December 21, 2020 Filing 4 Summonses Issued as to Myriad Women's Health, Inc. and Myriad Genetics, Inc. (please complete the top portion of the form and print out for use/service). (sam)
December 21, 2020 Filing 3 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,727,720 B2 ;US 7,332,277 B2. (sam)
December 21, 2020 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam)
December 21, 2020 Filing 1 COMPLAINT for Patent Infringement- filed with Jury Demand against Myriad Genetics, Inc., Myriad Women's Health, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3410418.) - filed by Ravgen, Inc. (Attachments: #1 Civil Cover Sheet, #2 Exhibit 1, #3 Exhibit 2, #4 Exhibit 3, #5 Exhibit 4, #6 Exhibit 5, #7 Exhibit 6, #8 Exhibit 7, #9 Exhibit 8, #10 Exhibit 9, #11 Exhibit 10, #12 Exhibit 11, #13 Exhibit 12, #14 Exhibit 13, #15 Exhibit 14, #16 Exhibit 15, #17 Exhibit 16, #18 Exhibit 17, #19 Exhibit 18, #20 Exhibit 19, #21 Exhibit 20, #22 Exhibit 21, #23 Exhibit 22, #24 Exhibit 23, #25 Exhibit 24, #26 Exhibit 25, #27 Exhibit 26, #28 Exhibit 27, #29 Exhibit 28, #30 Exhibit 29, #31 Exhibit 30, #32 Exhibit 31, #33 Exhibit 32, #34 Exhibit 33, #35 Exhibit 34, #36 Exhibit 35, #37 Exhibit 36)(sam)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Ravgen, Inc. v. Myriad Genetics, Inc. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Myriad Women's Health, Inc.
Represented By: Jack B. Blumenfeld
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Myriad Genetics, Inc.
Represented By: Jack B. Blumenfeld
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Ravgen, Inc.
Represented By: Michael J. Farnan
Represented By: Brian E. Farnan
Represented By: Deborah J. Mariottini
Represented By: Michael Ling
Represented By: John M. Desmarais
Represented By: Kerri-Ann Limbeek
Represented By: Brian D. Matty
Represented By: Jamie L. Kringstein
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?